Natco Pharma Ltd Quarterly Result
Natco Pharma Ltd
NSE: NATCOPHARM
Net Profit - Last Quarter
Natco Pharma Ltd Quarterly Results Key Highlights
- The revenue of Natco Pharma Ltd for the Mar '26 is ₹ 816.9 crore as compare to the Dec '25 revenue of ₹ 705.4 crore.
- This represent the growth of 15.81% The ebitda of Natco Pharma Ltd for the Mar '26 is ₹ 205.4 crore as compare to the Dec '25 ebitda of ₹ 216.8 crore.
- This represent the decline of -5.26% The net profit of Natco Pharma Ltd for the Mar '26 is ₹ 233.3 crore as compare to the Dec '25 net profit of ₹ 140.4 crore.
- This represent the growth of 66.17%.
Natco Pharma Ltd Quarterly Results Analysis
Market Price of Natco Pharma Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 28 Jul 2026 | 924.65 |
| 27 Jul 2026 | 927.15 |
| 24 Jul 2026 | 920.8 |
| 23 Jul 2026 | 918.85 |
| 22 Jul 2026 | 934.8 |
| 21 Jul 2026 | 961.95 |
| 20 Jul 2026 | 950.55 |
| 17 Jul 2026 | 945.75 |
| 16 Jul 2026 | 965.75 |
| 15 Jul 2026 | 969.75 |
Historical Revenue of Natco Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Natco Pharma Ltd
Historical EBITDA of Natco Pharma Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Natco Pharma Ltd
Historical Net Profit of Natco Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Natco Pharma Ltd
Natco Pharma Ltd News Hub
Natco Pharma invests USD 8 mn in bio-tech firm eGenesis
Natco Pharma announced that its wholly owned Canadian subsidiary, Natco Pharma (Canada) Inc. has mad
Read more
04 Sept 24
Natco Pharma fixes record date for second interim dividend
Natco Pharma has fixed 23 August 2024 as record date for second interim dividend for FY 2024-25. The
Read more
12 Aug 24
Board of Natco Pharma recommends dividend
Natco Pharma announced that the Board of Directors of the Company at its meeting held on 12 August 2
Read more
12 Aug 24
Natco Pharma schedules AGM
Natco Pharma announced that the 41th Annual General Meeting (AGM) of the company will be held on 30
Read more
12 Aug 24
Document
Popular Search
About Natco Pharma Ltd
- Natco Pharma Limited was originally incorporated on 19 September 1981 as private limited company as 'Natco Fine Pharmaceuticals Private Limited'.
- The name of the company was changed to Natco Pharma Limited and a fresh certificate of incorporation dated 30 December 1994 issued by the RoC, Andhra Pradesh. Natco Pharma is a vertically integrated and R&D focused pharmaceutical company that specialises in development, manufacturing and marketing of Finished Dosage Formulations (FDF) and Active Pharmaceutical Ingredients (APIs).
- The Company's focus is primarily on niche therapeutic areas and complex products.
- It sells products in over 40 countries.
- FDF products are sold in the United States, India, Europe and the rest of the world (RoW).
FAQs for Quarterly Results of Natco Pharma Ltd
What key financial metrics are included in Natco Pharma Ltd's quarterly results?
When does Natco Pharma Ltd announce its quarterly results?
How does Natco Pharma Ltd's quarterly performance impact its stock price?
What is the impact of Natco Pharma Ltd's quarterly results on dividends?
Are there any special announcements usually made during Natco Pharma Ltd's quarterly results?
